Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_assertion type Assertion NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_head.
- NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_assertion description "[The effects of peripheral MOR agonist (d-Ala2,NMe-Phe4,Gly5-ol (DAMGO)) and/or antagonist (naloxone methiodide) were explored in two models of acute hepatitis in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_provenance.
- NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_assertion evidence source_evidence_literature NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_provenance.
- NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_assertion SIO_000772 17299060 NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_provenance.
- NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_assertion wasDerivedFrom befree-20140225 NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_provenance.
- NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_assertion wasGeneratedBy ECO_0000203 NP660207.RAvosAn8YUwTlPKz64E93E9vb0zS6GGTcUQHiP3stFsl8130_provenance.